Universität zu Köln

Breuer, S., Fogelstrand, P., Lindskog, H., Osterberg, K., Luebke, T., Brunkwall, J. and Mattsson, E. (2014). Introduction of embryonic stem cells into vein grafts reduces intimal hyperplasia in mice. J. Cardiovasc. Surg., 55 (2). S. 235 - 247. TURIN: EDIZIONI MINERVA MEDICA. ISSN 1827-191X

Full text not available from this repository.

Abstract

Aim. Atherosclerosis with its cardiovascular events including cardiac and peripheral ischemia represents the main cause of death in the developed countries. Although interventional treatments like percutaneous transluminal angioplasty or stents are increasingly applied for the treatment of peripheral arterial disease, they are not always technically applicable or durable and bypass surgery is needed. Compared to synthetic grafts, vein grafts show a better patency especially when used for the lower leg as well as a lower risk for infection compared to synthetic grafts. Still the long-term patency rates are unsatisfactory due to accelerated intimal hyperplasia, a thickening of the vessel wall. The aim of this study was to elucidate, if the implantation of embryonic stem cells into vein grafts can reduce the development of intimal hyperplasia in a mouse in vivo model. Methods. In this study we implanted LacZ-tagged (ROSA26) murine embryonic stem cells into decellularized vein grafts. Control groups were: 1) untreated veins; 2) decellularized veins; 3) decellularized veins with gel and plastic film; and 4) decellularized veins with smooth muscle cells in gel surrounded by plastic film. Six weeks after insertion into the carotid artery of mice, the grafts were excised and analyzed immunohistochemically, morphologically, and by xgal staining and compared to the control groups. The Mann-Whitney U test was used to compare groups. Statistical significance was indicated by a value of P<0.05. Results. Decellularized veins with implanted stem cells showed significantly less intimal thickening compared to all control groups (intimal hyperplasia vs. luminal circumference mean +/- SD 7.3 +/- 3.5 mu m, median 8 mu m). The control groups: 1) untreated veins (60.3 +/- 25.5 mu m, median 58.5 mu m); 2) decellularized veins (53.9 +/- 22.4 mu m, median 48.4 mu m); 3) decellularized veins with gel and plastic film (70.6 +/- 22.4 mu m, median 72.6 mu m); and 4) decellularized veins with smooth muscle cells in gel surrounded by plastic film (73.5 +/- 18.1 mu m, median 73.6 mu m) all showed the same high degree of intimal hyperplasia. Conclusion. This study demonstrates that embryonic stem cells have a therapeutic competence to favourably modulate intimal hyperplasia in vivo.

Item Type:	Journal Article
Creators:	Creators Email ORCID ORCID Put Code Breuer, S. UNSPECIFIED UNSPECIFIED UNSPECIFIED Fogelstrand, P. UNSPECIFIED UNSPECIFIED UNSPECIFIED Lindskog, H. UNSPECIFIED UNSPECIFIED UNSPECIFIED Osterberg, K. UNSPECIFIED UNSPECIFIED UNSPECIFIED Luebke, T. UNSPECIFIED UNSPECIFIED UNSPECIFIED Brunkwall, J. UNSPECIFIED UNSPECIFIED UNSPECIFIED Mattsson, E. UNSPECIFIED UNSPECIFIED UNSPECIFIED
URN:	urn:nbn:de:hbz:38-441190
Journal or Publication Title:	J. Cardiovasc. Surg.
Volume:	55
Number:	2
Page Range:	S. 235 - 247
Date:	2014
Publisher:	EDIZIONI MINERVA MEDICA
Place of Publication:	TURIN
ISSN:	1827-191X
Language:	English
Faculty:	Unspecified
Divisions:	Unspecified
Subjects:	no entry
Uncontrolled Keywords:	Keywords Language ENDOTHELIAL PROGENITOR CELLS; SMOOTH-MUSCLE-CELLS; SAPHENOUS-VEIN; DECELLULARIZED VEIN; SEVERE ISCHEMIA; BLOOD-VESSELS; LEG BASIL; BYPASS; ANGIOPLASTY; ATHEROSCLEROSIS Multiple languages Cardiac & Cardiovascular Systems; Surgery; Peripheral Vascular Disease Multiple languages
URI:	http://kups.ub.uni-koeln.de/id/eprint/44119